AI-Powered Clinical Trial Matching: Transforming Patient Recruitment
Patient recruitment remains the single largest bottleneck in clinical development. Over 80% of trials fail to meet enrollment timelines, adding an estimated $8 million per day in delays for Phase III studies. AI-powered matching platforms address this by automating the identification of eligible patients from electronic health records, genomic profiles, and real-world data sources.
How AI Matching Works
These platforms typically ingest unstructured clinical data — physician notes, lab results, pathology reports, imaging records — and apply natural language processing to extract structured patient attributes. Those attributes are then matched against trial eligibility criteria, which can include hundreds of inclusion/exclusion conditions per protocol.
The most advanced systems go beyond keyword matching. They build patient graphs that map clinical concepts to standardized ontologies (ICD-10, SNOMED CT, MedDRA), enabling semantic matching that catches eligible patients missed by rule-based systems.
Market Landscape
The AI in clinical trials market was valued at approximately $2.1 billion in 2025 and is projected to exceed $18 billion by 2040. Patient recruitment and retention captures the largest segment, accounting for roughly 33% of the market. Over 70 companies now offer AI-driven clinical development solutions, with trial matching being a primary use case.
| Platform Type | Approach | Strengths |
|---|---|---|
| EHR-integrated | Mine patient records at the point of care | Real-time identification, high data depth |
| Federated networks | Query across hospital systems without moving data | Scale, privacy preservation |
| Marketplace models | Connect sponsors directly with research sites | Access to community sites, speed |
| Genomic-enhanced | Layer molecular data on clinical profiles | Precision matching for biomarker-driven trials |
Key Evaluation Criteria
- Data coverage
- Number of patient records accessible, geographic reach, and depth of clinical data (structured + unstructured)
- Matching accuracy
- Sensitivity and specificity of the algorithm — how many true positives are identified vs. false matches that waste site resources
- EHR integration
- Compatibility with major EHR systems (Epic, Cerner, Medidata) and time to deployment
- Regulatory posture
- HIPAA compliance, GDPR readiness, and adherence to 21 CFR Part 11 for clinical data handling
- Evidence of impact
- Published data on enrollment rate improvements, screening-to-randomization ratios, and time savings
Notable Industry Trends
Consolidation is reshaping the landscape. Tempus AI acquired Deep 6 AI in 2023, combining genomic testing capabilities with EHR-based trial matching. Meanwhile, agentic AI — autonomous agents that can execute multi-step workflows — is emerging as the next frontier, with platforms like ConcertAI deploying AI agents that automate feasibility assessment, site selection, and patient pre-screening in a single pipeline.
Decentralized and hybrid trial designs are also driving demand for AI matching tools that can identify patients across community health centers and rural sites, not just academic medical centers — expanding the eligible patient pool and improving trial diversity.